[Efficacy in viral inactivation of the concentrates of factor VIII and IX by the solvent/detergent procedure. Evaluation in patients with hemophilia]. 1991

C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
Centre de traitement de l'hémophilie, Hôpital Trousseau, Tours.

Human immunodeficiency virus (HIV) infection and hepatitis virus B or C (HBV, HCV) transmission are major risks following infusion of coagulation factor concentrates. Thus, several methods have been used to achieve viral inactivation of concentrates prepared from plasma collected from a large number of donors. In this study, 32 patients with haemophilia A or B (n = 31) or von Willebrand's disease (n = 1) were treated between 1987 and 1990 only with factor VIII or IX concentrates inactivated by the solvent-detergent procedure. During this period, none of these cases exhibited elevated liver enzymes (alanine amino transferase), and serological tests for HIV, HBV and HCV infections always remained negative. This suggests that the solvent-detergent procedure of concentrate inactivation is an efficient method to prevent not only HIV or HBV transmission but also HCV infection in haemophiliacs.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003902 Detergents Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. Cleansing Agents,Detergent Pods,Laundry Detergent Pods,Laundry Pods,Syndet,Synthetic Detergent,Agent, Cleansing,Agents, Cleansing,Cleansing Agent,Detergent,Detergent Pod,Detergent Pod, Laundry,Detergent Pods, Laundry,Detergent, Synthetic,Detergents, Synthetic,Laundry Detergent Pod,Laundry Pod,Pod, Detergent,Pod, Laundry,Pod, Laundry Detergent,Pods, Detergent,Pods, Laundry,Pods, Laundry Detergent,Synthetic Detergents
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
October 1998, Thrombosis and haemostasis,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
February 1971, JAMA,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
January 1985, Transfusion,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
January 1993, Vox sanguinis,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
January 1994, Annals of internal medicine,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
August 1994, Infusionstherapie und Transfusionsmedizin,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
August 1997, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
January 1991, Acta clinica Belgica,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
September 1980, Indian journal of medical sciences,
C Guerois, and A Parquet, and M Vicariot, and F F Lecoeur, and P Maisonneuve, and A M Courouce, and F Dubois, and Y Laurian
July 1987, Thrombosis research,
Copied contents to your clipboard!